Extended curettage, bone grafting, and spanning external fixation for the treatment of juxta-articular giant cell tumor of the bone around the knee

2017 ◽  
Vol 52 (4) ◽  
pp. 321
Author(s):  
AdelR Ahmed
Keyword(s):  
Giant Cell Tumor ◽  
External Fixation ◽  
Giant Cell ◽  
Bone Grafting ◽  
Cell Tumor ◽  
Extended Curettage

scholarly journals Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications

2016 ◽  
Vol 475 (3) ◽  
pp. 776-783 ◽  
Author(s):  
Joseph Benevenia ◽  
Steven M. Rivero ◽  
Jeffrey Moore ◽  
Joseph A. Ippolito ◽  
Daniel A. Siegerman ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Bone Grafting ◽  
Cell Tumor

Comparing clinical outcomes between extended curettage and wide resection in Enneking stage 3 giant cell tumor of bone

2021 ◽  
Author(s):  
Pakjai Tuntarattanapong ◽  
Pongsiri Piakong ◽  
Thanapon Chobpenthai ◽  
Bhasanan Sukanthanak ◽  
Piya Kiatisevi
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Clinical Outcomes ◽  
Cell Tumor ◽  
Wide Resection ◽  
Extended Curettage ◽  
Enneking Stage

Fibrosarcoma Development 15 Years After Curettage and Bone Grafting of Giant Cell Tumor of Bone

Orthopedics ◽  
2014 ◽  
Vol 37 (5) ◽  
pp. e512-e516 ◽  
Author(s):  
JuMing Li ◽  
Yan Zhu ◽  
YongZhong Wei
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Bone Grafting ◽  
Cell Tumor

Tricortical Bone Grafting with Limited Midcarpal and Carpometacarpal Fusion for the Treatment of Giant Cell Tumor of the Capitate

2020 ◽  
Author(s):  
Byron E. Chalidis ◽  
Christos G. Dimitriou ◽  
Panagiotis K. Givissis
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Bone Grafting ◽  
Functional Result ◽  
Cell Tumor ◽  
Satisfactory Outcome ◽  
Long Term Follow Up ◽  
Rare Lesion

Abstract Background Giant cell tumor (GCT) of capitate is a rare lesion that is challenging to treat. Case Description We present a case of a 12-year-old girl suffering from a GCT of the capitate. Wide excision combined with adjuvant treatment including hydrogen peroxide, alcohol, tricortical bone grafting, and limited midcarpal and carpometacarpal fusion achieved good functional result without evidence of tumor recurrence or radiocarpal degeneration at 8 years postoperatively. Clinical Relevance In this case with long-term follow-up, surgical treatment of capitate GCT with limited midcarpal and carpometacarpal fusion led to a satisfactory outcome despite the alteration of wrist kinematics.

scholarly journals A novel subchondral bone-grafting procedure for the treatment of giant-cell tumor around the knee

Medicine ◽  
2018 ◽  
Vol 97 (45) ◽  
pp. e13154 ◽  
Author(s):  
Minhao Wu ◽  
Shiyi Yao ◽  
Yuanlong Xie ◽  
Feifei Yan ◽  
Zhouming Deng ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Subchondral Bone ◽  
Bone Grafting ◽  
Cell Tumor ◽  
Grafting Procedure

scholarly journals Comparative Analysis of Two Surgical Treatment Options for Giant Cell Tumor of the Proximal Femur: Extended Curettage and Segmental Resection

2021 ◽  
Vol 11 ◽  
Author(s):  
Yuhao Yuan ◽  
Qing Liu ◽  
Yupeng Liu ◽  
Ziyi Wu ◽  
Wei Zhong ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Local Recurrence ◽  
Giant Cell Tumor ◽  
Giant Cell ◽  
Recurrence Rate ◽  
Proximal Femur ◽  
Cell Tumor ◽  
Evaluation Standard ◽  
Msts Score ◽  
Extended Curettage

AimAs a locally destructive intermediate bone tumor with low incidence, high recurrence rate, and difficulty in reconstruction, giant cell tumor of bone (GCTB) in the proximal femur has no unified surgical treatment standard. This study aimed to compare the differences in local recurrence, reconstruction durability, and postoperative function after treatment with either extended curettage (EC) or segmental resection (SR) for GCTB in the proximal femur so as to provide constructive suggestions for the rational selection of EC or SR operation scheme.Patients and Methods29 patients (15 men and 14 women) were included in this retrospective study, with a mean age of 32.1 years. According to the division method of proximal femur of International Society Of Limb Salvage (ISOLS), there was 1 case in the H1 area, 17 cases in the H2 area, 10 cases in the H1+H2 area, and 1 case in the H1+H2+H3 area. Among them were 11 cases of Campanacci grade II GCTB, 18 cases of Campanacci grade III GCTB, and 7 cases with pathological fractures. All patients underwent either EC or SR surgery. The Musculoskeletal Tumor Society (MSTS) score was used for patient evaluation. The operation effectiveness was analyzed according to the Mankin evaluation standard. Regular follow-up was performed to evaluate the recurrence rate, limb function, and long-term complications of the two surgical methods.ResultsAll patients were followed up for a mean of 60.4 months. Local recurrence occurred in one of 19 patients treated with EC (5.3%) and one of 10 patients treated with SR (10%). The MSTS score of lower limb function in patients in the EC group was better compared to patients in the SR group (P = 0.002). Complications occurred in 2 cases (10.5%) and 5 cases (50%) in the EC group (osteoarthritis, osteonecrosis) and SR group (joint stiffness, infection, prosthesis loosening), respectively, with significant differences between the two groups (P = 0.03). The operation effectiveness was analyzed according to the Mankin evaluation standard. The EC group showed an optimal rate of 94.7% (18/19) as opposed to 80% (8/10) in the SR group.ConclusionsFor GCTB in the proximal femur, when the tumor does not extensively involves the surrounding soft tissues, the articular surface was not damaged, and there is no pathological fracture with apparent displacement, EC surgery should be fully considered.

Sign in / Sign up

Export Citation Format

Share Document